Jia Zhou

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Transcription Factor

Top Venues

Cancer research

Science translational medicine

Dana-Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana-Farber Cancer Institute

United States

Research Fellow :: radiation oncology

Publications

Jeffrey Patterson-Fortin, Arindam Bose, Wei-Chih Tsai, Carter Grochala, Huy Nguyen, Jia Zhou, Kalindi Parmar, Jean-Bernard Lazaro, Joyce F Liu, Kelsey McQueen, Geoffrey I Shapiro, David E Kozono, Alan D' Andrea
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers. Cancer research 82 (20) (2022)
Anniina Farkkila, Alfredo Rodríguez, Jaana Oikkonen, Doga C Gulhan, Huy Nguyen, Julieta Domínguez, Sandra Ramos, Caitlin E Mills, Fernando Pérez-Villatoro, Jean-Bernard Lazaro, Jia Zhou, Connor S Clairmont, Lisa A Moreau, Peter J Park, Peter Karl Sorger, Sampsa Hautaniemi, Sara Frías, Alan D' Andrea
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1-Deficient Cells. Cancer research 81 (10) (2021)
Salomon Manier, Daisy Huynh, Yu J Shen, Jia Zhou, Timur Yusufzai, Karma Z Salem, Richard Y Ebright, Jiantao Shi, Jihye Park, Siobhan V Glavey, William G Devine, Chia-Jen Liu, Xavier Leleu, Bruno Quesnel, Catherine Roche-Lestienne, John K Snyder, Lauren E Brown, Nathanael Gray, James E Bradner, Luke Whitesell, John A Porco, Irene M Ghobrial
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma. Science translational medicine 9 (389) (2018)